Simone I. Richardson
Johannesburg, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.
Journal: The Journal of infection
Published: October 28, 2025
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 22, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Advancing the course of HIV genomics research in Africa.
Journal: BMJ global health
Published: January 20, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functions.
Journal: iScience
Published: January 15, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories.
Journal: Viruses
Published: November 12, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
Journal: Journal of virology
Published: July 02, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
Journal: PLOS global public health
Published: June 02, 2024
SARS-CoV-2 humoral immunity in people living with HIV-1.
Journal: Trends in immunology
Published: May 17, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families.
Journal: PLoS pathogens
Published: April 19, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibody.
Journal: Structure (London, England : 1993)
Published: February 05, 2024
Last Updated: 09/26/2026